Your browser doesn't support javascript.
loading
Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma Patients.
Martini, Dylan J; Evans, Sean T; Liu, Yuan; Shabto, Julie M; Uner, Ogul E; Olsen, T Anders; Brown, Jacqueline T; Russler, Greta Anne; Yantorni, Lauren; Caulfield, Sarah; Goldman, Jamie M; Nazha, Bassel; Harris, Wayne B; Master, Viraj A; Kucuk, Omer; Carthon, Bradley C; Bilen, Mehmet Asim.
Afiliación
  • Martini DJ; Massachusetts General Hospital, Department of Medicine, Boston, MA; Winship Cancer Institute of Emory University, Atlanta, GA.
  • Evans ST; Winship Cancer Institute of Emory University, Atlanta, GA; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA.
  • Liu Y; Departments of Biostatistics and Bioinformatics, Emory University, Atlanta, GA.
  • Shabto JM; Winship Cancer Institute of Emory University, Atlanta, GA; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA.
  • Uner OE; Winship Cancer Institute of Emory University, Atlanta, GA; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA.
  • Olsen TA; Winship Cancer Institute of Emory University, Atlanta, GA; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA.
  • Brown JT; Winship Cancer Institute of Emory University, Atlanta, GA; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA.
  • Russler GA; Winship Cancer Institute of Emory University, Atlanta, GA.
  • Yantorni L; Winship Cancer Institute of Emory University, Atlanta, GA.
  • Caulfield S; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA; Department of Pharmaceutical Services, Emory University School of Medicine, Atlanta, GA.
  • Goldman JM; Winship Cancer Institute of Emory University, Atlanta, GA; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA.
  • Nazha B; Winship Cancer Institute of Emory University, Atlanta, GA; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA.
  • Harris WB; Winship Cancer Institute of Emory University, Atlanta, GA; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA.
  • Master VA; Department of Urology, Emory University School of Medicine, Atlanta, GA.
  • Kucuk O; Winship Cancer Institute of Emory University, Atlanta, GA; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA.
  • Carthon BC; Winship Cancer Institute of Emory University, Atlanta, GA; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA.
  • Bilen MA; Winship Cancer Institute of Emory University, Atlanta, GA; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA. Electronic address: mehmet.a.bilen@emory.edu.
Clin Genitourin Cancer ; 20(1): 53-59, 2022 02.
Article en En | MEDLINE | ID: mdl-34922840
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Mucositis / Hipertensión / Neoplasias Renales Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Clin Genitourin Cancer Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Gabón Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Mucositis / Hipertensión / Neoplasias Renales Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Clin Genitourin Cancer Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Gabón Pais de publicación: Estados Unidos